Recursion
VerifiedRecursion is a biotechnology company that uses an AI-driven platform to discover and develop new medicines. It combines automated wet-lab experiments with machine learning models in what it calls a "lab-in-the-loop" system, mapping disease biology, designing drug candidates, and advancing them toward clinical trials. The company maintains its own pipeline of investigational drugs in areas like oncology and rare disease, and also partners with pharmaceutical companies to apply its technology to specific drug discovery challenges. This is not a consumer software product but a platform and company aimed at pharmaceutical partners, investors, and researchers interested in AI-driven biology and drug development, rather than individual end users seeking a subscription tool.
Recursion at a glance
- What it is
- Recursion is a biotechnology company that uses an AI-driven platform to discover and develop new medicines.
- Who it's for
- Most useful for anyone who needs results in the AI Healthcare, Wellness & Medical area without a specialist on staff.
- Primary use case
- Dive into Recursion's innovative approach to decoding biology.
- CategoryAI Healthcare, Wellness & Medical
- PricingFree Tier
- Starting priceFree, paid plans available
- Credit cardNo credit card required
- Foundation modelFine-tuned
- Bring your own keyNot supported
- RatingNo reviews yet. Be the first to rate.
Video Spot
Overview
Recursion is a biotechnology company that uses an AI-driven platform to discover and develop new medicines. It combines automated wet-lab experiments with machine learning models in what it calls a "lab-in-the-loop" system, mapping disease biology, designing drug candidates, and advancing them toward clinical trials. The company maintains its own pipeline of investigational drugs in areas like oncology and rare disease, and also partners with pharmaceutical companies to apply its technology to specific drug discovery challenges. This is not a consumer software product but a platform and company aimed at pharmaceutical partners, investors, and researchers interested in AI-driven biology and drug development, rather than individual end users seeking a subscription tool.
Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us today!
In detail
Recursion is a biotechnology company building an AI-powered platform to discover and develop new medicines. Rather than being a typical software-as-a-service tool, it operates as an integrated drug discovery and development engine that combines automated laboratory experiments with computational machine learning models.
The platform is designed for pharmaceutical partners, investors, and the scientific community rather than general consumers. Recursion maintains its own pipeline of investigational drugs, including programs in oncology and rare diseases such as familial adenomatous polyposis and hypophosphatasia, several of which have reached clinical trial phases.
Recursion's approach relies on what it calls a "lab-in-the-loop" system: a continuous cycle of disease-specific cellular engineering, high-dimensional biological data collection, and supercompute-powered foundation models. This is paired with an integrated Design-Make-Test-Learn process that connects biology, molecule design, and clinical development within one system rather than handing off work between separate tools or teams.
What differentiates Recursion, according to the company, is this end-to-end integration. It states that its system can narrow millions of candidate molecules down to a short list of synthetically accessible options before any compounds are sent to physical labs, and that some programs have advanced quality candidates after synthesizing far fewer compounds than is typical in the industry. The company also partners with pharmaceutical companies, applying its platform to help identify novel disease targets and design molecules against difficult targets, citing a track record of achieving milestones with partners.
Overall, Recursion presents itself as a science and technology company decoding biology to develop medicines faster, at scale, with its platform underpinning both its own wholly owned pipeline and collaborative work with pharma partners.
Common uses
- Discovering novel drug targets for diseases with high unmet need
- Designing drug candidate molecules against historically difficult biological targets
- Advancing internally owned drug programs through preclinical and clinical trial phases
- Partnering with pharmaceutical companies on joint drug discovery portfolios
- Reducing the number of compounds that must be synthesized during drug candidate development
Pros
- Integrates biological experimentation and computational modeling in one connected system
- Maintains a diverse internal pipeline across oncology and rare disease
- Has an established partnership track record with pharmaceutical companies
- States it can reduce the number of compounds synthesized compared to industry norms
Cons
- Not a consumer or general-business software tool, so it has limited relevance outside pharma and biotech
- No stated pricing, plans, or trial information since it is not a subscription product
- Primarily geared toward pharmaceutical partners and investors rather than individual users
- Specific technical details of the AI models and algorithms are not disclosed on the page
Generated from the listing's details and not yet checked by a Zoipi editor.
Key Features
- AI-enabled drug discovery platform: combines automated lab experiments with machine learning models
- Lab-in-the-loop system: a continuous cycle connecting physical automation and computational analysis
- Design-Make-Test-Learn process: integrated workflow from biology insight to molecule design to testing
- Disease-specific cellular engineering: used to generate high-dimensional biological data
- Molecule narrowing: uses its system to reduce millions of candidate molecules to a synthetically accessible shortlist
- Clinical pipeline: wholly owned programs spanning oncology and rare disease indications
- Pharma partnerships: collaborates with partners to target specific therapeutic challenges
Best For
- Anyone replacing a manual ai healthcare, wellness & medical process with something faster
- Anyone testing the space without an upfront budget
- Buyers who want a highly rated, well-established option
Pricing Model
Free Tier. Generous ongoing free tier you can start with, no credit card needed. Paid plans unlock higher limits.
Pricing Breakdown
Screenshots
Live preview of Recursion's website.
Frequently asked questions
Community Reviews & Discussion
0 reviews · replies are moderated before they appear.
- No reviews yet — be the first to review Recursion.